Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. (OTCMKTS:FSNUY) saw a significant increase in short interest in December. As of December 15th, there was short interest totaling 98,734 shares, an increase of 2,262.6% from the November 30th total of 4,179 shares. Based on an average daily trading volume, of 170,340 shares, the days-to-cover ratio is presently 0.6 days. Based on an average daily trading volume, of 170,340 shares, the days-to-cover ratio is presently 0.6 days.

Wall Street Analysts Forecast Growth

FSNUY has been the topic of several research reports. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, December 15th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Fresenius SE & Co. in a research report on Monday, October 27th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy”.

Fresenius SE & Co. Trading Up 0.8%

Fresenius SE & Co. stock traded up $0.11 during mid-day trading on Thursday, hitting $14.40. The stock had a trading volume of 16,185 shares, compared to its average volume of 63,416. Fresenius SE & Co. has a 12 month low of $8.58 and a 12 month high of $33.93. The stock has a market capitalization of $32.17 billion, a PE ratio of 26.18 and a beta of 0.77. The company has a current ratio of 1.26, a quick ratio of 0.99 and a debt-to-equity ratio of 0.49. The stock has a 50-day simple moving average of $14.82 and a two-hundred day simple moving average of $13.68.

Fresenius SE & Co. (OTCMKTS:FSNUY) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.02. The company had revenue of $6.29 billion during the quarter, compared to analyst estimates of $6.38 billion. Fresenius SE & Co. had a net margin of 5.26% and a return on equity of 9.72%. As a group, sell-side analysts forecast that Fresenius SE & Co. will post 0.79 EPS for the current year.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.